Form 4: Regal Rexnord CFO Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Regal Rexnord's EVP and CFO, Robert Rehard, sold 7,704 shares of common stock for approximately $216.72 per share under a pre-arranged plan.
Summary
- Robert Rehard, Executive Vice President and Chief Financial Officer of Regal Rexnord Corp (RRX), reported the sale of 7,704 shares of common stock.
- The transaction occurred on February 9, 2026, at a weighted average price of $216.72 per share, with prices ranging from $216.28 to $216.83.
- This sale was conducted pursuant to a Rule 10b5-1(c) plan, indicating a pre-scheduled transaction.
- Following the sale, Mr. Rehard directly beneficially owns 34,153.954 shares of Regal Rexnord common stock.
- Mr. Rehard also holds various Stock Appreciation Rights (SARs) with exercise prices ranging from $74.04 to $168.47, expiring between May 10, 2027, and February 23, 2034.
- The SARs have different vesting schedules, either 40% on the second anniversary, 60% on the third, 80% on the fourth, and 100% on the fifth anniversary of the grant date, or 34% on the first, 67% on the second, and 100% on the third anniversary of the grant date.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While it is an insider sale, the disclosure of a Rule 10b5-1 plan mitigates any negative interpretation, suggesting a pre-planned liquidity event rather than a reaction to new company developments.
Positives
- The transaction was executed under a Rule 10b5-1(c) plan, which demonstrates a pre-planned sale and mitigates concerns about insider trading based on non-public information.
Negatives
- An insider sale, even if pre-planned, reduces the direct equity exposure of a key executive, which some investors might perceive as a minor negative signal, though this is largely offset by the 10b5-1 plan.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those executed under Rule 10b5-1 plans, are routine occurrences in the market and typically do not indicate significant shifts in broader industry trends or competitive dynamics.
Comparison to Industry Standards
- Insider selling under a Rule 10b5-1 plan is a widely accepted and standard practice for executives to manage personal liquidity and diversify their holdings without concerns of trading on material non-public information. This filing aligns with typical corporate governance practices for executive stock transactions.
- No specific comparable companies, projects, or results are mentioned in this Form 4 to allow for a direct comparative assessment against industry benchmarks.
Stakeholder Impact
- The primary impact is on the reporting person's personal equity holdings and financial planning. There is minimal direct impact on other stakeholders such as shareholders, employees, customers, suppliers, or creditors, as this is a personal transaction by an executive.
Key Dates
| Date | Description |
|---|---|
| 05/10/2019 | Grant date for Stock Appreciation Rights with an exercise price of $76.99, expiring 05/10/2027. |
| 05/09/2020 | Grant date for Stock Appreciation Rights with an exercise price of $74.04, expiring 05/09/2028. |
| 02/18/2021 | Grant date for Stock Appreciation Rights with an exercise price of $84.39, expiring 02/18/2030. |
| 05/08/2021 | Grant date for Stock Appreciation Rights with an exercise price of $78.05, expiring 05/08/2029. |
| 02/23/2022 | Grant date for Stock Appreciation Rights with an exercise price of $133.77, expiring 02/23/2031. |
| 02/23/2023 | Grant date for Stock Appreciation Rights with an exercise price of $151.27, expiring 02/23/2032. |
| 02/23/2024 | Grant date for Stock Appreciation Rights with an exercise price of $154.20, expiring 02/23/2033. |
| 02/23/2025 | Grant date for Stock Appreciation Rights with an exercise price of $168.47, expiring 02/23/2034. |
| 02/09/2026 | Date of common stock transaction by Robert Rehard. |
| 02/11/2026 | Date the Form 4 filing was signed. |
Recommendation
holdA Form 4 filing detailing a pre-planned insider sale, especially under a 10b5-1 plan, typically does not provide sufficient information to warrant a change in investment recommendation. It reflects an executive's personal financial planning rather than a signal about the company's fundamental performance or future prospects.
Keywords
Regal Rexnord, RRX, Form 4, insider trading, stock sale, Robert Rehard, EVP and CFO, 10b5-1 plan, Stock Appreciation Rights, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.